Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2000
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046651A1 Composition and method for modulating dendritic cell-T interaction
10/25/2000EP1046410A2 Calcium and magnesium containing phosphate binding agent for the treatment of hyperphosphatemia
10/25/2000EP1046399A1 HCV combination therapy, containing ribavirin in association with antioxidants
10/25/2000EP1046397A2 Novel bioactivating substance
10/25/2000EP1046396A2 Soy protein and plant sterol containing composition for the reduction of low density lipoprotein cholesterol concentration
10/25/2000EP1046395A1 Plaster for topical use containing heparin and diclofenac
10/25/2000EP1046393A1 Composition containing at least one bicyclic aromatic compound and at least one 2-alkyl-1-alkanol or an ester, and its use
10/25/2000EP1046391A2 Use of aminosubstituted hydroxybenzophenones as photostable UV-filters in cosmetic and pharmaceutical preparations
10/25/2000EP1046389A1 Cosnetic composition in particular a make-up composition comprising a pyrrolopyrrole pigment
10/25/2000EP1046345A2 Preparation for administration to animals and feeding method thereof
10/25/2000EP1045936A1 Aqueous compositions comprising complexing agents and uses therof
10/25/2000EP1045920A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy
10/25/2000EP1045915A2 Regulation of biological events using multimeric chimeric proteins
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP1045902A1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME
10/25/2000EP1045901A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4
10/25/2000EP1045897A1 Enzyme catalyzed therapeutic agents
10/25/2000EP1045863A1 Detoxication of active pharmaceutical substances using cyclodextrine oligomers
10/25/2000EP1045856A1 Novel aromatic amides, preparation method and application as medicines
10/25/2000EP1045853A1 Synthesis of combretastatin a-4 prodrugs and trans-isomers thereo f
10/25/2000EP1045851A1 Substituted porphyrins
10/25/2000EP1045850A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
10/25/2000EP1045849A1 Purine derivatives having phosphodiesterase iv inhibition activity
10/25/2000EP1045847A1 Hydrate of 5- 4- 2- (n-methyl-n- (2-pyridil)amino) ethoxy]benzyl] thiazolidine-2, 4-dione maleic acid salt
10/25/2000EP1045846A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045843A1 Inhibitors of farnesyl-protein transferase
10/25/2000EP1045842A2 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
10/25/2000EP1045840A1 Hypolipidemic benzothiazepine compounds
10/25/2000EP1045839A2 Novel amines as pharmaceutical agents
10/25/2000EP1045837A1 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
10/25/2000EP1045836A1 Pyridones as src family sh2 domain inhibitors
10/25/2000EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2000EP1045833A1 2,3-substituted indole compounds as cox-2 inhibitors
10/25/2000EP1045832A2 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
10/25/2000EP1045830A1 Alpha-aminoamide derivatives useful as analgesic agents
10/25/2000EP1045826A1 Process for the preparation of isopropyl-methyl- 2-(3-n-propoxyphenoxy)ethyl]amine
10/25/2000EP1045825A1 Novel polyethoxylated castor oil, process of making the same and formulations thereof
10/25/2000EP1045822A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
10/25/2000EP1045709A1 Method and device for in-situ formulation of a medicinal solution for parenteral application
10/25/2000EP1045703A1 Stabilization of lipid:dna formulations during nebulization
10/25/2000EP1045700A1 Oral delivery of nucleic acid vaccines by particulate complexes
10/25/2000EP1045699A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle
10/25/2000EP1045697A2 Extension of cellular lifespan, methods and reagents
10/25/2000EP1045696A1 Oral oil sorbing composition
10/25/2000EP1045695A1 Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease
10/25/2000EP1045694A1 Method of increasing bone volume using non-naturally-occurring fp selective agonists
10/25/2000EP1045693A1 Aminophenoxyacetic acid derivatives as neuroprotectants
10/25/2000EP1045692A1 Skin protection composition
10/25/2000EP1045691A1 Statin-carboxyalkylether combinations
10/25/2000EP1045690A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
10/25/2000EP1045689A1 Synthesis of phenstatin and prodrugs thereof
10/25/2000EP1045681A1 METHOD AND COMPOSITIONS FOR $i(IN SITU) FORMATION OF PROTECTIVE AND/OR MEDICATED FILMS ON BODY TISSUE
10/25/2000EP1045636A1 Pharmaceutical compositions and methods for the treatment of failing myocardial tissue
10/25/2000EP1014998A4 Polymeric compositions
10/25/2000EP0785770B1 Hemorrhoidal compositions and method of use
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000EP0714418B1 Cosmetic melanins
10/25/2000CN1271365A Compounds with anti-KS and anti-HIV activity
10/25/2000CN1271363A 3'-N-modified 6-0-substituted erythromycin ketolide derivatives having antibacterial activity
10/25/2000CN1271361A Tetrazole-containing rapamycin analogs with shortened half-lives
10/25/2000CN1271360A 1,3-dioxolo/4,5-Hl/2,3/benzodiazepine derivatives as AMPA/Kainate receptor inhibitors
10/25/2000CN1271359A Novel compounds
10/25/2000CN1271358A Oxazolidinone derivatives and pharmaceutical compositions
10/25/2000CN1271357A bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors
10/25/2000CN1271356A Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for corresponding antifungal agent
10/25/2000CN1271354A Compounds possessing neuronal activity
10/25/2000CN1271353A Furansulfonic acid derivatives and pharmaceutical compositions containing the same
10/25/2000CN1271349A Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
10/25/2000CN1271347A 1,5-diphenylpypazole derivatives
10/25/2000CN1271342A Synthesis of clasto-lactacystin-beta-lactone and analogs thereof
10/25/2000CN1271341A Substituted 2-pyrolidinone activators of PKC
10/25/2000CN1271338A Processes and intermediates useful to make antifolates
10/25/2000CN1271292A Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
10/25/2000CN1271291A Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and use thereof
10/25/2000CN1271290A Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and use thereof
10/25/2000CN1271289A Osteoblast-specific mitogens and drugs containing such compounds
10/25/2000CN1271288A Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
10/25/2000CN1271287A New use of budesonide and formoterol
10/25/2000CN1271286A Coated dosage unit
10/25/2000CN1271285A Remedial agent for baldness and other diseases
10/25/2000CN1271284A Vitronectin receptor antagonist
10/25/2000CN1271283A Endothelin antogonist and a renin-angiotensin system inhibitor as a combined preparation
10/25/2000CN1271282A Oral compositions of levosimendan
10/25/2000CN1271281A Medicamenet formulation with a controlled release of an active agent
10/25/2000CN1271280A A transdermal drug delivery system for anti-inflammatory analogesic agent comprising diclofenac diethylammonium, and the manufacturing method thereof
10/25/2000CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines
10/25/2000CN1271278A Treatment of conduct disorder
10/25/2000CN1271276A Controlled release of drugs delivered by sublingual or buccal administration
10/25/2000CN1271275A Small particle liposome aerosols for delivery of atni-cancer drugs
10/25/2000CN1271251A 2-methyl-thieno-benzodiazepine formulation
10/25/2000CN1271250A Polyamine treatment of neurological disorders
10/25/2000CN1270960A Process for preparing growth hormone cinogenic agent
10/25/2000CN1270959A 4-phenyl pyridine derivatives
10/25/2000CN1270958A Beta-lactan
10/25/2000CN1270833A Bone fracture setting medicine powder
10/25/2000CN1270817A Tea-oil general saponin for preventing and treating cardiac and cerebral vascular diseases and preparation thereof
10/25/2000CN1270812A Burn and scald treating medicine and its preparation
10/25/2000CN1270809A Application of tanhin polyphenolic B magnesium in preparing medicine for treating chronic hepatosis
1 ... 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 6233 6234 6235 6236 6237 6238 6239 6240 6241 6242 ... 7860